Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04800471 · ClinicalTrials.gov registry record · NA
Improving Glycemic Control in DM2 Patients in the Ambulatory Setting
A NA study, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT04800471 is a NA study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 30 participants.
The verdict
NCT04800471, a NA study, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
More than 10.5% of the US population has diabetes mellitus. The objective of this pilot study is to evaluate whether smart insulin pens combined with CGM devices can improve glucose control in patients with type 2 diabetes (T2D)
Interventions
- DEVICE Smart insulin pens and CGM
- OTHER Point of Care Glucose Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-08-16 |
| Est. Completion | 2024-07-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04800471
The ClinicalTrials.gov registry entry for NCT04800471 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Smart insulin pens and CGM is the first listed.
NCT04800471 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04800471 about?
NCT04800471 is a clinical study titled "Improving Glycemic Control in DM2 Patients in the Ambulatory Setting". More than 10.5% of the US population has diabetes mellitus. The objective of this pilot study is to evaluate whether smart insulin pens combined with CGM devices can improve glucose control in patients with type 2 diabetes (T2D)
What is the current status of trial NCT04800471?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2021-08-16. Estimated completion is 2024-07-09.
What interventions are being tested in trial NCT04800471?
The interventions under investigation include: Smart insulin pens and CGM (DEVICE), Point of Care Glucose Group (OTHER).
Who is sponsoring clinical trial NCT04800471?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.